Anistreplase (also known as APSAC or anisoylated plasminogen streptokinase activator complex) is a thrombolytic agent composed of two primary components: streptokinase and human lys-plasminogen. These components are chemically modified by the addition of a p-anisoyl group to temporarily inactivate the complex, allowing for controlled activation at the site of a thrombus. It is grouped under the following drug class(es): Antithrombotic agents and Thrombolytics. The directory classifies it as a discontinued API with a peptide source/manufacturing origin. Other names for this substance include Anistreplasa and Anisoylated plasminogen streptokinase activator complex. Its PubChem SID is 504687242.
Anistreplase
| CAS No | 81669-57-0 |
|---|---|
| Molecular Formula | C₂₅₆₉H₃₉₂₈N₇₄₆O₇₈₁S₄₀ |
| Molecular Weight | ~ 131 kDa |
| Synonyms | N/A |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Anistreplase (also known as APSAC or anisoylated plasminogen streptokinase activator complex) is a thrombolytic agent composed of two primary components: streptokinase and human lys-plasminogen.
The listed CAS number is 81669-57-0.
The listed molecular formula is C₂₅₆₉H₃₉₂₈N₇₄₆O₇₈₁S₄₀.
The listed molecular weight is ~ 131 kDa.
N/A.
The source lists Anistreplasa and Anisoylated plasminogen streptokinase activator complex.